Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Eczema Herpeticum: Would You Know It If You Saw It?

Blanter M, Vickers J, Russo M, Safai B.

Pediatr Emerg Care. 2015 Aug;31(8):586-8. doi: 10.1097/PEC.0000000000000516.

PMID:
26241712
2.

Diagnostic and prognostic biomarkers in melanoma.

Weinstein D, Leininger J, Hamby C, Safai B.

J Clin Aesthet Dermatol. 2014 Jun;7(6):13-24. Review.

3.

Images in clinical medicine. Scombroid poisoning.

Vickers J, Safai B.

N Engl J Med. 2013 Jun 6;368(23):e31. doi: 10.1056/NEJMicm1300169. No abstract available.

4.

The debate between gadolinium versus erythropoietin in a renal transplant patient with nephrogenic systemic fibrosis.

Hashemi P, Sina B, Rietkerk W, Safai B.

J Nephrol. 2013 Jan-Feb;26(1):48-54. doi: 10.5301/jn.5000159. Review.

PMID:
22573525
5.

Superantigens in dermatology.

Macias ES, Pereira FA, Rietkerk W, Safai B.

J Am Acad Dermatol. 2011 Mar;64(3):455-72; quiz 473-4. doi: 10.1016/j.jaad.2010.03.044. Review.

PMID:
21315950
6.

Use of low-energy X-rays in the treatment of superficial nonmelanomatous skin cancers.

Bodner WR, Hilaris BS, Alagheband M, Safai B, Mastoras CA, Saraf S.

Cancer Invest. 2003 Jun;21(3):355-62.

PMID:
12901281
7.

Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death.

Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kajstura J.

Diabetes. 2001 Oct;50(10):2363-75.

8.

Cutaneous malignancies of keratinocytic origin.

Bagheri MM, Safai B.

Clin Dermatol. 2001 May-Jun;19(3):244-52. Review. No abstract available.

PMID:
11479036
9.

Prevalence of HTLV type I infection in Iran: a serological and genetic study.

Safai B, Huang JL, Boeri E, Farid R, Raafat J, Schutzer P, Ahkami R, Franchini G.

AIDS Res Hum Retroviruses. 1996 Aug 10;12(12):1185-90.

PMID:
8844023
10.

Clinical manifestations of Kaposi's sarcoma.

Safai B.

Oncology (Williston Park). 1996 Jun;10(6 Suppl):13-23; discussion 37-8. Review.

11.

Histologic predictors of survival in acquired immunodeficiency syndrome-associated Kaposi's sarcoma.

Niedt GW, Myskowski PL, Urmacher C, Niedzwiecki D, Chapman D, Krown SE, Safai B.

Hum Pathol. 1992 Dec;23(12):1419-26.

PMID:
1468779
12.

Malignant neoplasms associated with human immunodeficiency virus infection.

Safai B, Diaz B, Schwartz J.

CA Cancer J Clin. 1992 Mar-Apr;42(2):74-95. Review. No abstract available. Erratum in: CA Cancer J Clin 1992 Jul-Aug;42(4):254.

13.

HIV-related malignancies.

Schwartz JJ, Dias BM, Safai B.

Dermatol Clin. 1991 Jul;9(3):503-15. Review.

PMID:
1873928
14.

Increased plasma prostacyclin in AIDS.

Roy P, Safai B, Kahn NN, Sinha AK.

J Acquir Immune Defic Syndr. 1991;4(2):205-6. No abstract available.

PMID:
1987358
15.

HIV-associated malignancies.

Safai B, Dias BM, Schwartz JJ, Boulier I.

Antibiot Chemother (1971). 1991;43:69-95. Review. No abstract available.

PMID:
1883225
16.

Interferon in the treatment of AIDS-associated Kaposi's sarcoma: the American experience.

Safai B, Bason M, Friedman-Birnbaum R, Nisce L.

J Invest Dermatol. 1990 Dec;95(6 Suppl):166S-169S. Review.

17.

Lymphoma and other HIV-associated malignancies.

Myskowski PL, Straus DJ, Safai B.

J Am Acad Dermatol. 1990 Jun;22(6 Pt 2):1253-60. Review.

PMID:
2193954
18.

Angiocentric T-cell lymphoma associated with human T-cell lymphotropic virus type I infection.

McNutt NS, Smoller BR, Kline M, Cohen SR, Hsu A, Saltz L, Cash K, Safai B.

Arch Pathol Lab Med. 1990 Feb;114(2):170-5.

PMID:
2302032
19.

Histology of early lesions of AIDS-associated Kaposi's sarcoma.

Niedt GW, Myskowski PL, Urmacher C, Niedzwiecki D, Chapman D, Safai B.

Mod Pathol. 1990 Jan;3(1):64-70.

PMID:
2308922
20.

Kaposi's sarcoma/AIDS cofactors.

Gross DJ, Safai B.

Int J Dermatol. 1989 Nov;28(9):571-3. Review. No abstract available.

PMID:
2684881
21.

No evidence for true HTLV-I or HIV-1 antibodies in Finnish Lapps.

Ranki A, Zheng Y, Kirjarinta M, Karvonen J, Saxinger C, Ashorn P, Safai B, Krohn K.

AIDS Res Hum Retroviruses. 1989 Jun;5(3):321-6.

PMID:
2730804
22.

Basal cell carcinomas and lymphoma: biologic behavior and associated factors in sixty-three patients.

Parnes R, Safai B, Myskowski PL.

J Am Acad Dermatol. 1988 Dec;19(6):1017-23.

PMID:
3204176
23.

The immunology of basal cell carcinoma.

Myskowski PL, Safai B.

Int J Dermatol. 1988 Nov;27(9):601-7. Review. No abstract available.

PMID:
3068167
24.

AIDS-associated Kaposi's sarcoma: variables associated with survival.

Myskowski PL, Niedzwiecki D, Shurgot BA, Kaufman D, Krown SE, Nisce L, Safai B.

J Am Acad Dermatol. 1988 Jun;18(6):1299-306.

PMID:
2968378
25.
26.

Cancers-associated with HIV infection.

Safai B, Lynfield R, Lowenthal DA, Koziner B.

Anticancer Res. 1987 Sep-Oct;7(5B):1055-67. Review.

PMID:
3324937
27.

Pathophysiology and epidemiology of epidemic Kaposi's sarcoma.

Safai B.

Semin Oncol. 1987 Jun;14(2 Suppl 3):7-12. Review. Erratum in: Semin Oncol 1987 Dec;14(4):viii.

PMID:
3299718
28.

A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope.

Palker TJ, Matthews TJ, Clark ME, Cianciolo GJ, Randall RR, Langlois AJ, White GC, Safai B, Snyderman R, Bolognesi DP, et al.

Proc Natl Acad Sci U S A. 1987 Apr;84(8):2479-83.

29.

Epidermal Langerhans cells--a target for HTLV-III/LAV infection.

Tschachler E, Groh V, Popovic M, Mann DL, Konrad K, Safai B, Eron L, diMarzo Veronese F, Wolff K, Stingl G.

J Invest Dermatol. 1987 Feb;88(2):233-7.

30.

Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine.

Yarchoan R, Berg G, Brouwers P, Fischl MA, Spitzer AR, Wichman A, Grafman J, Thomas RV, Safai B, Brunetti A, et al.

Lancet. 1987 Jan 17;1(8525):132-5.

PMID:
2879972
31.

Malignant neoplasms associated with the HTLV-III/LAV infection.

Safai B, Lowenthal DA, Koziner B.

Antibiot Chemother (1971). 1987;38:80-98. Review. No abstract available.

PMID:
3310866
32.

Identification with the monoclonal antibody 26.163 of a determinant shared by the beta chains of the gene products of the HLA-DR, DQ, and DP loci.

Igarashi M, Gebhard DH, Chen YX, Safai B, Evans RL, Ferrone S.

Hum Immunol. 1986 Aug;16(4):347-55.

PMID:
2428781
33.

Antigen-specific and polyclonal B-cell responses in patients with acquired immunodeficiency disease syndrome.

Katz IR, Krown SE, Safai B, Oettgen HF, Hoffmann MK.

Clin Immunol Immunopathol. 1986 Jun;39(3):359-67.

PMID:
2938858
34.

Importance of complete cutaneous examination for the detection of malignant melanoma.

Rigel DS, Friedman RJ, Kopf AW, Weltman R, Prioleau PG, Safai B, Lebwohl MG, Eliezri Y, Torre DP, Binford RT Jr, et al.

J Am Acad Dermatol. 1986 May;14(5 Pt 1):857-60.

PMID:
3711396
35.

The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome.

Safai B, Johnson KG, Myskowski PL, Koziner B, Yang SY, Cunningham-Rundles S, Godbold JH, Dupont B.

Ann Intern Med. 1985 Nov;103(5):744-50. Review.

PMID:
3901851
36.

Spectrum of Kaposi's sarcoma in the epidemic of AIDS.

Safai B, Sarngadharan MG, Koziner B, Godbold J, Myskowski PL, Cunningham-Rundles S, Johnson K, Gold J, Krown S, Dupont B.

Cancer Res. 1985 Sep;45(9 Suppl):4646s-4648s.

37.

Beta 2-microglobulin as a prognostic marker for development of AIDS.

Bhalla RB, Safai B, Pahwa S, Schwartz MK.

Clin Chem. 1985 Aug;31(8):1411-2. No abstract available.

38.

Human leukocyte antigen associations in basal cell carcinoma.

Myskowski PL, Pollack MS, Schorr E, Dupont B, Safai B.

J Am Acad Dermatol. 1985 Jun;12(6):997-1000.

PMID:
3874217
39.
40.

Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients.

Robey WG, Safai B, Oroszlan S, Arthur LO, Gonda MA, Gallo RC, Fischinger PJ.

Science. 1985 May 3;228(4699):593-5.

PMID:
2984774
41.

Basal cell carcinoma following chronic otitis media.

Myskowski PL, Safai B.

Int J Dermatol. 1985 Mar;24(2):120-1. No abstract available.

PMID:
4039301
42.

Basal cell carcinoma and breast carcinoma following repeated fluoroscopic examinations of the chest.

Myskowski PL, Gumpertz E, Safai B.

Int J Dermatol. 1985 Mar;24(2):122-3.

PMID:
2985515
43.

Radiation therapy of Kaposi's sarcoma in AIDS. Memorial Sloan-Kettering experience.

Nisce LZ, Safai B.

Front Radiat Ther Oncol. 1985;19:133-7. No abstract available.

PMID:
3920122
44.

Interferons and other biological response modifiers in the treatment of Kaposi's sarcoma.

Krown SE, Real FX, Krim M, Cunningham-Rundles S, Koziner B, Myskowski PL, Safai B, Oettgen HF.

Front Radiat Ther Oncol. 1985;19:138-49. No abstract available.

PMID:
3838523
45.

Cytotoxic effector mechanisms in AIDS.

Cunningham-Rundles S, Metroka CE, Safai B, Krim M, Rubin BY, Hayward G.

Adv Exp Med Biol. 1985;187:97-110. No abstract available.

PMID:
2412419
46.

HTLV-III in cells cultured from semen of two patients with AIDS.

Zagury D, Bernard J, Leibowitch J, Safai B, Groopman JE, Feldman M, Sarngadharan MG, Gallo RC.

Science. 1984 Oct 26;226(4673):449-51.

PMID:
6208607
47.

Granulocytic sarcoma. A new finding in the setting of preleukemia.

Sadick N, Edlin D, Myskowski PL, Gold E, Gee T, Safai B.

Arch Dermatol. 1984 Oct;120(10):1341-3.

PMID:
6593007
48.

HLA-A,B,C and DR antigen frequencies in acquired immunodeficiency syndrome (AIDS) patients with opportunistic infections.

Pollack MS, Gold J, Metroka CE, Safai B, Dupont B.

Hum Immunol. 1984 Oct;11(2):99-103.

PMID:
6333416
49.
50.

Kaposi's sarcoma. Gastrointestinal involvement correlation with skin findings and immunologic function.

Saltz RK, Kurtz RC, Lightdale CJ, Myskowski P, Cunningham-Rundles S, Urmacher C, Safai B.

Dig Dis Sci. 1984 Sep;29(9):817-23.

PMID:
6468212

Supplemental Content

Support Center